Amended Quarterly Report (10-q/a)
November 16 2017 - 4:19PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q/A
(Amendment
No. 1)
(Mark
One)
[X]
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For
the quarterly period ended September 30, 2017
OR
[ ]
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Commission
File Number 001-33624
Amedica
Corporation
(Exact
name of registrant as specified in its charter)
DELAWARE
|
|
84-1375299
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(IRS
Employer
Identification
No.)
|
1885
West 2100 South, Salt Lake City, UT
|
|
84119
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
(801)
839-3500
(Registrant’s
telephone number, including area code)
Indicate
by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such
reports); and (2) has been subject to such filing requirements for the past 90 days: Yes [X] No [ ]
Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files); Yes [X] No [ ]
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller
reporting company” in Rule 12b-2 of the Exchange Act:
Large
accelerated filer
|
[ ]
|
Accelerated
filer
|
[ ]
|
Non-accelerated
filer
|
[ ]
(Do not check if a smaller reporting company)
|
Smaller
reporting company
|
[X]
|
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): [ ] Yes [X]
No
Indicate
the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:
3,022,073
shares of common stock, $0.01 par value, were outstanding at November 16, 2017
EXPLANATORY
NOTE
The
purpose of this Amendment No. 1 to Amedica Corporation’s Quarterly Report on Form 10-Q for the quarter ended September 30,
2017, filed with the Securities and Exchange Commission on November 14, 2017 (the “Form 10-Q”), is solely to furnish
Exhibit 101 to the Form 10-Q. Exhibit 101 to this report provides the consolidated financial statements and related notes from
the Form 10-Q formatted in XBRL (eXtensible Business Reporting Language).
The
Company is filing Exhibit 101 in accordance with the temporary hardship exemption provided by Rule 201 of Regulation S-T, which
extended the date by which the interactive data file is required to be submitted by six business days.
No
other changes have been made to the Form 10-Q. This Amendment No. 1 to the Form 10-Q speaks, as of the original filing date of
the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update
in any way disclosures made in the original Form 10-Q.
Pursuant
to Rule 406T of Regulation S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration
statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.
PART
II
ITEM
6. EXHIBITS
*These
exhibits were previously filed or furnished as an exhibit to Amedica Corporation’s quarterly report on Form 10-Q for the
quarterly period ended September 30, 2017, filed with the Securities and Exchange Commission on November 14, 2017
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
AMEDICA
CORPORATION
|
|
|
Date:
November 16, 2017
|
/s/
B. Sonny Bal
|
|
B.
Sonny Bal
|
|
Chief
Executive Officer
(Principal
Executive Officer)
|
AMEDICA CORP (NASDAQ:AMDA)
Historical Stock Chart
From Mar 2024 to Apr 2024
AMEDICA CORP (NASDAQ:AMDA)
Historical Stock Chart
From Apr 2023 to Apr 2024